Tag Archives: appetite control

How Long Does Saxenda Stay in Your Body?

How Long Does Saxenda Stay in Your Body? UK Guide Written by Bolt Pharmacy Published on 19/7/2026 How long does Saxenda stay in your body after your last injection? Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist prescribed for weight management in the UK. Understanding its duration in your system is essential for managing […]

Saxenda Nausea at Night

Saxenda Nausea at Night: Causes, Management and When to Seek Help Written by Bolt Pharmacy Published on 19/7/2026 Saxenda (liraglutide) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with comorbidities. Nausea is the most frequently reported side effect, affecting approximately 39% of patients during clinical trials. Many people […]

How Long Does 0.25 mg Ozempic Stay in Your System?

How Long Does 0.25 mg Ozempic Stay in Your System? Written by Bolt Pharmacy Published on 19/7/2026 How long does 0.25 mg Ozempic stay in your system? Understanding the duration of semaglutide in your body is essential for managing type 2 diabetes treatment effectively. Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist with an […]

How Much GLP-1 to Take

How Much GLP-1 to Take: UK Dosing Guidelines Written by Bolt Pharmacy Published on 19/7/2026 Determining the correct GLP-1 dose is a personalised medical decision that depends on the specific medication prescribed, your treatment goals, and individual health factors. GLP-1 receptor agonists—including semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)—are used to manage […]

Saxenda and Blood Thinners

Saxenda and Blood Thinners: Safety and Monitoring Guidance Written by Bolt Pharmacy Published on 17/4/2026 Saxenda and blood thinners can generally be used together safely, though specific monitoring may be required. Saxenda (liraglutide 3 mg) is a GLP-1 receptor agonist licensed for weight management in adults with obesity or overweight with related health conditions. Blood […]

Saxenda Thigh or Stomach?

Saxenda Thigh or Stomach: Choosing the Best Injection Site Written by Bolt Pharmacy Published on 8/6/2026 Saxenda (liraglutide) is a once-daily subcutaneous injection for weight management, approved in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities. As a GLP-1 receptor agonist, it helps regulate appetite […]

Chromium Picolinate and Berberine

Chromium Picolinate and Berberine: Uses, Safety and Interactions Written by Bolt Pharmacy Published on 17/4/2026 Chromium picolinate and berberine are two food supplements increasingly used for metabolic health support, particularly in relation to blood glucose regulation. Chromium picolinate is a highly absorbable form of the trace mineral chromium, which may enhance insulin sensitivity. Berberine is […]

Chromium Picolinate and Berberine

Chromium Picolinate and Berberine: Uses, Safety and Interactions Written by Bolt Pharmacy Published on 17/4/2026 Chromium picolinate and berberine are two food supplements increasingly used for metabolic health support, particularly in relation to blood glucose regulation. Chromium picolinate is a highly absorbable form of the trace mineral chromium, which may enhance insulin sensitivity. Berberine is […]

Wegovy; Injection To Pill

Switching From Wegovy Injection to Pill: UK Prescribing Guide Written by Bolt Pharmacy Published on 15/7/2026 Switching from Wegovy injection to pill is a clinically supervised process that requires careful planning rather than a simple dose swap. Both the weekly injection and the daily tablet contain semaglutide, a GLP-1 receptor agonist used for weight management, […]

Can You Get Retatrutide As a Pill?

Retatrutide in Pill Form: What UK Patients Need to Know Written by Bolt Pharmacy Published on 15/7/2026 Retatrutide in pill form is not currently available — and understanding why matters for anyone researching this investigational medicine. Retatrutide is a novel ‘triple agonist’ developed by Eli Lilly, targeting the GLP-1, GIP, and glucagon receptors simultaneously. It […]